• Info
  • Insider Ownership

Insider Trading & Ownership of Jason A. Keyes

Location
La Jolla, CA
Summary
The estimated net worth of Jason A. Keyes is at least $105,791 dollars as of 23 May 2025. Jason A. Keyes is the Chief Financial Officer of Equillium, Inc. and owns shares of Equillium, Inc. (EQ) stock worth about $82.3K. Jason A. Keyes is the Director of Sesen Bio, Inc. and owns shares of Carisma Therapeutics Inc. (CARM) stock worth about $23.5K.
Signature
/s/ Paul Lytle, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jason A. Keyes and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Jason A. Keyes has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $105,791.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Equillium, Inc. ($82,311).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jason A. Keyes

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EQ Equillium, Inc. Chief Financial Officer $82,311 14 Feb 2025
CARM Sesen Bio, Inc. Director $23,480 22 Jun 2022
ACTU ACTUATE THERAPEUTICS, INC. Director 22 May 2025

Insider Transactions Reported by Jason A. Keyes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored